Read More

Sharps Technology Issues Letter To Shareholders Covering The Announced Asset Purchase Agreement To Acquire InjectEZ Prefillable Syringe Manufacturing Facility And The Associated $400M 10-Year Purchase Agreement With Nephron Pharmaceuticals

Transformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare market Company has a capitalization strategy through debt that has

STSS

Read More

EXCLUSIVE: Cannabis CEOs Address How To Attract Investors Amid Changing Regulations

"The right investors are not scared by the complexity of cannabis regulations," TILT Holdings (CSE: TILT) (OTC: TLLTF) CEO Tim Conder said at the Benzinga Cannabis Capital Conference.

CSE:TILT